Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
Call to Action Policy Makers Must Increase Medicare Advantage Oversight and Rein in Overpayments May 5, 2022 Five related articles focusing on MA inequities, denials, oversight, waste and more
The start of a new year offers the perfect opportunity to reset, refocus, and commit to becoming the healthiest version of yourself
Our newest blog breaks down whats actually happening during a plateau and why this phase is more common (and necessary) than you think
Across the major trials, average weight loss rises with each receptor added: 13.7% for semaglutide, 20.2% for tirzepatide, and 28.3% for retatrutide
This highlights the need for vigilant monitoring and risk stratification across all patient subgroups
US$ 21.79
US$ 23.43
US$ 20.89
US$ 27.60
US$ 24.08
US$ 22.70
US$ 28.45
US$ 23.04
